BioCurate, together with partners MTPConnect, Uniquest, MDPP and the BRIDGE program, were the successful recipients of the $22.4M MRFF BioMedical Translation Bridge (BTB) Program. To assist BioCurate with the coordination and operational requirements needed to enable the Program’s successful establishment and first call for projects, BioCurate is pleased to announce Dr Tifelle Reisinger’s appointment as Program Manager.
Dr Tifelle Reisinger is a medicinal chemist with 9 years drug discovery experience in the pharmaceutical and CRO industries in France, UK and Australia. She has worked on programs from hit identification through to candidate nomination in the fields of oncology, cardiovascular diseases and neurosciences.
Tifelle relocated from the UK to Melbourne in 2017 as Head of Business Development, Asia Pacific for Domainex, a drug discovery service company. With a strong client-focus and business acumen, Tifelle generated and managed a portfolio of clients with ownership of the full sales cycle, with biotech companies, VCs and leading academic research institutes across Australia. She has built successful relationships based on understanding client needs, creating bespoke solutions and delivering value to international clients and utilising her business development, project and contract management skills.
BioCurate is focused on turning discoveries into therapeutics, and is building a team of highly-experienced individuals capable of working collaboratively to ensure the company’s success. We are delighted that Tifelle has decided to join the BioCurate team!
Dr Tifelle Reisinger commenced in her new role on 1 April 2019.